Pharmacometrics Phisticuffs 3* – Is Biostatistics a more important partner for drug development than Pharmacometrics, or are they equal partners?

Co-Chair(s)

• 

  Stacey Tannenbaum, PhD, FISoP (she/her/hers)

  Consultant and Coach to the MIDD Community
  SJTPharm LLC
  Northbrook, Illinois, United States

Speaker(s)

• RF

  Richard C. Franzese, MPhys, DPhil

  Director
  GSK
• JR

  James A. Rogers, PhD (he/him/his)

  Vice President, Statistics
  Metrum Research Group